The global industry for CAR T-cell therapy in treating Non-Hodgkin's lymphoma is experiencing substantial growth. This trend is fueled by several factors, including increasing prevalence of Non-Hodgkin's lymphoma, advancements in CAR T-cell therapy technology, and increasing implementation by healthcare providers. The market is categorized based on… Read More